Epistasis between FLG and IL4R Genes on the Risk of Allergic Sensitization: Results from Two Population-Based Birth Cohort Studies

Ali H Ziyab 1, Jenny Hankinson 2, Susan Ewart 3, Eric Schauberger 4, Kamilla Kopec-Harding 5, Hongmei Zhang 6, Adnan Custovic 7, Hasan Arshad 8 9, Angela Simpson 2, Wilfried J Karmaus 6

Affiliations

19 February 2018

-

doi: 10.1038/s41598-018-21459-x

Abstract

Immune-specific genes as well as genes responsible for the formation and integrity of the epidermal barrier have been implicated in the pathogeneses of allergic sensitization. This study sought to determine whether an epistatic effect (gene-gene interaction) between genetic variants within interleukin 4 receptor (IL4R) and filaggrin (FLG) genes predispose to the development of allergic sensitization. Data from two birth cohort studies were analyzed, namely the Isle of Wight (IOW; n = 1,456) and the Manchester Asthma and Allergy Study (MAAS; n = 1,058). In the IOW study, one interaction term (IL4R rs3024676 × FLG variants) showed statistical significance (interaction term: P = 0.003). To illustrate the observed epistasis, stratified analyses were performed, which showed that FLG variants were associated with allergic sensitization only among IL4R rs3024676 homozygotes (OR, 1.97; 95% CI, 1.27-3.05; P = 0.003). In contrast, FLG variants effect was masked among IL4R rs3024676 heterozygotes (OR, 0.53; 95% CI, 0.22-1.32; P = 0.175). Similar results were demonstrated in the MAAS study. Epistasis between immune (IL4R) and skin (FLG) regulatory genes exist in the pathogenesis of allergic sensitization. Hence, genetic susceptibility towards defective epidermal barrier and deviated immune responses could work together in the development of allergic sensitization.

Conflict of interest statement

The authors declare no competing interests.

Similar articles

Allergic sensitization and filaggrin variants predispose to the comorbidity of eczema, asthma, and rhinitis: results from the Isle of Wight birth cohort.

Ziyab AH, Karmaus W, Zhang H, Holloway JW, Steck SE, Ewart S, Arshad SH.Clin Exp Allergy. 2014 Sep;44(9):1170-8. doi: 10.1111/cea.12321.PMID: 24708301 Free PMC article.

Interplay of filaggrin loss-of-function variants, allergic sensitization, and eczema in a longitudinal study covering infancy to 18 years of age.

Ziyab AH, Karmaus W, Yousefi M, Ewart S, Schauberger E, Holloway JW, Zhang H, Arshad SH.PLoS One. 2012;7(3):e32721. doi: 10.1371/journal.pone.0032721. Epub 2012 Mar 5.PMID: 22403702 Free PMC article. Clinical Trial.

Association of filaggrin variants with asthma and rhinitis: is eczema or allergic sensitization status an effect modifier?

Ziyab AH, Karmaus W, Zhang H, Holloway JW, Steck SE, Ewart S, Arshad SH.Int Arch Allergy Immunol. 2014;164(4):308-18. doi: 10.1159/000365990. Epub 2014 Sep 23.PMID: 25277085 Free PMC article.

Filaggrin gene defects and the risk of developing allergic disorders.

Osawa R, Akiyama M, Shimizu H.Allergol Int. 2011 Mar;60(1):1-9. doi: 10.2332/allergolint.10-RAI-0270. Epub 2011 Dec 25.PMID: 21173567 Review.

[FILAGGRIN GENE NULL-MUTATIONS AND ATOPIC DISEASES].

Pipinić IS, Macan J.Acta Med Croatica. 2015;69(5):467-73.PMID: 29087092 Review. Croatian.

Cited by

The link between atopic dermatitis and asthma- immunological imbalance and beyond.

Yaneva M, Darlenski R.Asthma Res Pract. 2021 Dec 15;7(1):16. doi: 10.1186/s40733-021-00082-0.PMID: 34911576 Free PMC article. Review.

Longitudinal atopic dermatitis endotypes: An atopic march paradigm that includes Black children.

Biagini JM, Kroner JW, Baatyrbek Kyzy A, Gonzales A, He H, Stevens M, Grashel B, Spagna D, Paul S, Patel R, Bucci A, Sherenian MG, Murrison LB, Martin LJ, Khurana Hershey GK.J Allergy Clin Immunol. 2022 May;149(5):1702-1710.e4. doi: 10.1016/j.jaci.2021.09.036. Epub 2021 Oct 18.PMID: 34673050 Free PMC article.

Filaggrin gene mutations with special reference to atopic dermatitis.

Gupta J, Margolis DJ.Curr Treat Options Allergy. 2020 Sep;7(3):403-413. doi: 10.1007/s40521-020-00271-x. Epub 2020 Jul 10.PMID: 33585163 Free PMC article.

Early-life inhalant allergen exposure, filaggrin genotype, and the development of sensitization from infancy to adolescence.

Simpson A, Brough HA, Haider S, Belgrave D, Murray CS, Custovic A.J Allergy Clin Immunol. 2020 Mar;145(3):993-1001. doi: 10.1016/j.jaci.2019.08.041. Epub 2019 Oct 17.PMID: 31629803 Free PMC article.

Blood Biomarkers of Sensitization and Asthma.

Sonntag HJ, Filippi S, Pipis S, Custovic A.Front Pediatr. 2019 Jun 19;7:251. doi: 10.3389/fped.2019.00251. eCollection 2019.PMID: 31275911 Free PMC article. Review.

KMEL References

https://pubmed.ncbi.nlm.nih.gov/

References

  1.  
    1. Busse WW. The role of allergy in disease. Immunol. Rev. 2011;242:5–9. doi: 10.1111/j.1600-065X.2011.01036.x. - DOI - PubMed
  2.  
    1. Salo PM, et al. Prevalence of allergic sensitization in the United States: results from the National Health and Nutrition Examination Survey (NHANES) 2005-2006. J. Allergy Clin. Immunol. 2014;134:350–359. doi: 10.1016/j.jaci.2013.12.1071. - DOI - PMC - PubMed
  3.  
    1. Weidinger S, et al. Genome-wide scan on total serum IgE levels identifies FCER1A as novel susceptibility locus. PLoS Genet. 2008;4:e1000166. doi: 10.1371/journal.pgen.1000166. - DOI - PMC - PubMed
  4.  
    1. Castro-Giner F, et al. A pooling-based genome-wide analysis identifies new potential candidate genes for atopy in the European Community Respiratory Health Survey (ECRHS) BMC Med. Genet. 2009;10:128. doi: 10.1186/1471-2350-10-128. - DOI - PMC - PubMed
  5.  
    1. Wan YI, et al. A genome-wide association study to identify genetic determinants of atopy in subjects from the United Kingdom. J. Allergy Clin. Immunol. 2011;127:223–231. doi: 10.1016/j.jaci.2010.10.006. - DOI - PubMed
  6.  
    1. Bonnelykke K, et al. Meta-analysis of genome-wide association studies identifies ten loci influencing allergic sensitization. Nat. Genet. 2013;45:902–906. doi: 10.1038/ng.2694. - DOI - PMC - PubMed
  7.  
    1. Granada M, et al. A genome-wide association study of plasma total IgE concentrations in the Framingham Heart Study. J. Allergy Clin. Immunol. 2012;129:840–845. doi: 10.1016/j.jaci.2011.09.029. - DOI - PMC - PubMed
  8.  
    1. Potaczek DP, Kabesch M. Current concepts of IgE regulation and impact of genetic determinants. Clin. Exp. Allergy. 2012;42:852–871. doi: 10.1111/j.1365-2222.2011.03953.x. - DOI - PubMed
  9.  
    1. Irvine AD, McLean WH, Leung DY. Filaggrin mutations associated with skin and allergic diseases. N. Engl. J. Med. 2011;365:1315–1327. doi: 10.1056/NEJMra1011040. - DOI - PubMed
  10.  
    1. van den Oord RA, Sheikh A. Filaggrin gene defects and risk of developing allergic sensitisation and allergic disorders: systematic review and meta-analysis. BMJ. 2009;339:b2433. doi: 10.1136/bmj.b2433. - DOI - PMC - PubMed
  11.  
    1. Kraft P, Hunter DJ. Genetic risk prediction–are we there yet? N. Engl. J. Med. 2009;360:1701–1703. doi: 10.1056/NEJMp0810107. - DOI - PubMed
  12.  
    1. Wei WH, Hemani G, Haley CS. Detecting epistasis in human complex traits. Nat. Rev. Genet. 2014;15:722–733. doi: 10.1038/nrg3747. - DOI - PubMed
  13.  
    1. Zuk O, Hechter E, Sunyaev SR, Lander ES. The mystery of missing heritability: Genetic interactions create phantom heritability. Proc. Natl. Acad. Sci. 2012;109:1193–1198. doi: 10.1073/pnas.1119675109. - DOI - PMC - PubMed
  14.  
    1. Vercelli D. Discovering susceptibility genes for asthma and allergy. Nat. Rev. Immunol. 2008;8:169–182. doi: 10.1038/nri2257. - DOI - PubMed
  15.  
    1. Adjers K, Pessi T, Karjalainen J, Huhtala H, Hurme M. Epistatic effect of IL1A and IL4RA genes on the risk of atopy. J. Allergy Clin. Immunol. 2004;113:445–447. doi: 10.1016/j.jaci.2003.12.582. - DOI - PubMed
  16.  
    1. Kabesch M, et al. IL-4/IL-13 pathway genetics strongly influence serum IgE levels and childhood asthma. J. Allergy Clin. Immunol. 2006;117:269–274. doi: 10.1016/j.jaci.2005.10.024. - DOI - PubMed
  17.  
    1. Ziyab AH, et al. Interplay of filaggrin loss-of-function variants, allergic sensitization, and eczema in a longitudinal study covering infancy to 18 years of age. PLoS One. 2012;7:e32721. doi: 10.1371/journal.pone.0032721. - DOI - PMC - PubMed
  18.  
    1. Soto-Ramirez N, et al. The interaction of genetic variants and DNA methylation of the interleukin-4 receptor gene increase the risk of asthma at age 18 years. Clin. Epigenetics. 2013;5:1. doi: 10.1186/1868-7083-5-1. - DOI - PMC - PubMed
  19.  
    1. Custovic A, et al. The National Asthma Campaign Manchester Asthma and Allergy Study. Pediatr. Allergy Immunol. 2002;13(Suppl 15):32–37. doi: 10.1034/j.1399-3038.13.s.15.3.x. - DOI - PubMed
  20.  
    1. Palmer CN, et al. Common loss-of-function variants of the epidermal barrier protein filaggrin are a major predisposing factor for atopic dermatitis. Nat. Genet. 2006;38:441–446. doi: 10.1038/ng1767. - DOI - PubMed
  21.  
    1. Zeger SL, Liang KY. Longitudinal data analysis for discrete and continuous outcomes. Biometrics. 1986;42:121–130. doi: 10.2307/2531248. - DOI - PubMed
  22.  
    1. Pan W. Akaike’s information criterion in generalized estimating equations. Biometrics. 2001;57:120–125. doi: 10.1111/j.0006-341X.2001.00120.x. - DOI - PubMed
  23.  
    1. Benjamini Y, Hochberg Y. Controlling the False Discovery Rate: A Practical and Powerful Approach to Multiple Testing. Journal of the Royal Statistical Society. Series B (Methodological) 1995;57:289–300.
  24.  
    1. Liu X, et al. Associations between specific serum IgE response and 6 variants within the genes IL4, IL13, and IL4RA in German children: the German Multicenter Atopy Study. J. Allergy Clin. Immunol. 2004;113:489–495. doi: 10.1016/j.jaci.2003.12.037. - DOI - PubMed
  25.  
    1. Loza MJ, Chang BL. Association between Q551R IL4R genetic variants and atopic asthma risk demonstrated by meta-analysis. J. Allergy Clin. Immunol. 2007;120:578–585. doi: 10.1016/j.jaci.2007.05.019. - DOI - PubMed
  26.  
    1. Kelly-Welch AE, Hanson EM, Boothby MR, Keegan AD. Interleukin-4 and interleukin-13 signaling connections maps. Science. 2003;300:1527–1528. doi: 10.1126/science.1085458. - DOI - PubMed
  27.  
    1. Kubo A, Nagao K, Amagai M. Epidermal barrier dysfunction and cutaneous sensitization in atopic diseases. J. Clin. Invest. 2012;122:440–447. doi: 10.1172/JCI57416. - DOI - PMC - PubMed
  28.  
    1. De Benedetto A, Kubo A, Beck LA. Skin barrier disruption: a requirement for allergen sensitization? J. Invest. Dermatol. 2012;132:949–963. doi: 10.1038/jid.2011.435. - DOI - PMC - PubMed
  29.  
    1. Chan IH, et al. Gene-gene interactions for asthma and plasma total IgE concentration in Chinese children. J. Allergy Clin. Immunol. 2006;117:127–133. doi: 10.1016/j.jaci.2005.09.031. - DOI - PubMed
  30.  
    1. Olson S. Population genetics. Seeking the signs of selection. Science. 2002;298:1324–1325. - PubMed
  31.  
    1. Omolo B, Zhang H, Karmaus W. Cautions of Using Allele-Based Tests Under Heterosis. Int. J. Stats. Med. Res. 2013;2:47–54.
  32.  
    1. Penrose LS. Evidence of heterosis in man. Proc R Soc Lond B Biol Sci. 1955;144:203–213. doi: 10.1098/rspb.1955.0047. - DOI - PubMed
  33.  
    1. Comings DE, MacMurray JP. Molecular heterosis: a review. Mol. Genet. Metab. 2000;71:19–31. doi: 10.1006/mgme.2000.3015. - DOI - PubMed
  34.  
    1. Bunn HF. The triumph of good over evil: protection by the sickle gene against malaria. Blood. 2013;121:20–25. doi: 10.1182/blood-2012-08-449397. - DOI - PubMed
  35.  
    1. Roberts G, et al. Trends in cutaneous sensitization in the first 18 years of life: results from the 1989 Isle of Wight birth cohort study. Clin. Exp. Allergy. 2012;42:1501–1509. doi: 10.1111/j.1365-2222.2012.04074.x. - DOI - PubMed
  36.  
    1. Baye TM, et al. Differences in candidate gene association between European ancestry and African American asthmatic children. PLoS One. 2011;6:e16522. doi: 10.1371/journal.pone.0016522. - DOI - PMC - PubMed
  37.  
    1. Cummings P. The relative merits of risk ratios and odds ratios. Arch. Pediatr. Adolesc. Med. 2009;163:438–445. doi: 10.1001/archpediatrics.2009.31. - DOI - PubMed

Page Navigation